News

The manufacturing site Lindopharm GmbH, a company of Aristo Pharma Group specialized on production of sachets and hormones since 1947, was visited by representatives of the Armenian Scientific Centre of Drug and Medical Technology Expertise in frames of Eurasian Economic Union (EAEU) inspection in the end of January 2023.

The inspection was aimed to check the site complies with current GMP (Good Manufacturing Practice) guidelines of the Eurasian Economic Council, as well as to monitor the quality management system ensuring production and delivery of high-quality pharmaceuticals to EAEU markets (Armenia, Belarus, Kazakhstan, Kyrgyzstan and Russian Federation).

The range of products manufactured by Lindopharm GmbH for Aristo Pharma portfolio is rather wide. Fosfomycin Esparma and ESPA-NAC are delivered to the pharmaceutical markets of Russia and CIS at the moment. The quality assurance manager of Aristo Pharma Russia & CIS took part in the inspection herself and got an opportunity to study the production features and monitor the quality control process and storage conditions.

The EAEU GMP certificate was issued to Lindopharm GmbH as the inspection result to prove once again the highest level of the site readiness to constant checks and monitoring.